Skip to main content
. Author manuscript; available in PMC: 2023 Jul 17.
Published in final edited form as: Circ Cardiovasc Imaging. 2023 Jan 17;16(1):e014068. doi: 10.1161/CIRCIMAGING.122.014068

Table 1. A summary of the original (2009)39 and revised (2018)12 Lake Louise criteria.

Lake Louise criteria
Lake Louise Criteria (2009)39:
In the setting of clinically suspected myocarditis, CMR findings are consistent with myocardial inflammation if at least 2 of the following 3 criteria are present:
   - Regional or global myocardial SI increase in T2-weighted images (edema)
   - Increased global myocardial early gadolinium enhancement ratio between myocardium and skeletal muscle in gadolinium-enhanced T1-weighted images (hyperemia)
   - At least 1 focal lesion with nonischemic regional distribution in inversion recovery-prepared gadolinium-enhanced T1-weighted images (*LGE*) (necrosis/fibrosis)
The presence of LV dysfunction or pericardial effusion provides additional, supportive evidence or myocarditis.
Updated Lake Louise criteria (2018)12:
Any 2 out of 2 are present:
   - T2-based imaging: regional high T2 SI or Global T2 SI ratio ≥ 2.0 in T2W CMR images or Regional or global increase of myocardial T2 relaxation time
   - T1-based imaging: regional or global increase of native myocardial T1 or ECV or areas with high SI in a nonischemic distribution pattern in LGE images
Supportive criteria:
   - Pericardial effusion in cine CMR images or High signal intensity of the pericardium in LGE images, T1-mapping or T2-mapping
   - Systolic LV wall motion abnormality in cine CMR images

CMR = cardiac magnetic resonance LGE = late gadolinium enhancement LV = left ventricle

SI = signal intensity T2W = T2-weighted ECV = extracellular volume